(Q51372135)

English

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.

scientific article published on 27 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Monika Manocha

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Pramod Chandra Pal

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

K T Chitralekha

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Beena Elizabeth Thomas

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Vinita Tripathi

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Siddhartha Dutta Gupta

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Ramesh Paranjape

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Smita Kulkarni

8

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

D Nageswara Rao

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

language of work or name

0 references

publication date

27 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

23

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

48-49

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

5599-5617

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

The Role of Mucosal Immunity in Prevention of HIV Transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Detection of IgA inhibiting the interaction between gp120 and soluble CD4 receptor in serum and saliva of HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches--a personal and historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Antigenic analysis of HIV type 1 external envelope (Env) glycoprotein C2 region: implication for the structure of Env.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Inducing a cell-mediated immune response against peptides of the Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Murine Peyer's patch T cell clones. Characterization of antigen-specific helper T cells for immunoglobulin A responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Effects of Parenteral and Enteral Nutrition on Gut-Associated Lymphoid Tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Bioactive fragment of human IL-1beta [163-171] modulates the immune response to synthetic peptides of HIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Intrinsic and extrinsic factors in protein antigenic structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Structural requirements for synthetic immunogens to induce measles virus specific CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.06.031

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/16099080

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51372135&oldid=1589575713"